BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 24076646)

  • 21. Molecular regulation of phosphate metabolism by fibroblast growth factor-23-klotho system.
    Cheng CY; Kuro-o M; Razzaque MS
    Adv Chronic Kidney Dis; 2011 Mar; 18(2):91-7. PubMed ID: 21406293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The FGF23/KLOTHO Regulatory Network and Its Roles in Human Disorders.
    Kinoshita S; Kawai M
    Vitam Horm; 2016; 101():151-74. PubMed ID: 27125741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone-kidney axis in systemic phosphate turnover.
    Razzaque MS
    Arch Biochem Biophys; 2014 Nov; 561():154-8. PubMed ID: 24997362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of klotho deletion from bone during chronic kidney disease.
    Kaludjerovic J; Komaba H; Lanske B
    Bone; 2017 Jul; 100():50-55. PubMed ID: 28232146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype.
    Bai X; Dinghong Q; Miao D; Goltzman D; Karaplis AC
    Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E79-88. PubMed ID: 18984852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease.
    Sawires HK; Essam RM; Morgan MF; Mahmoud RA
    Nephron; 2015; 129(4):293-9. PubMed ID: 25766835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphate and FGF23 in the renoprotective benefit of RAAS inhibition.
    de Seigneux S; Martin PY
    Pharmacol Res; 2016 Apr; 106():87-91. PubMed ID: 26900884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The FGF23/Klotho axis in the regulation of mineral and metabolic homeostasis.
    Kawai M
    Horm Mol Biol Clin Investig; 2016 Oct; 28(1):55-67. PubMed ID: 26943611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FGF23-αKlotho as a paradigm for a kidney-bone network.
    Kuro-O M; Moe OW
    Bone; 2017 Jul; 100():4-18. PubMed ID: 27847255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of parathyroid hormone in Klotho-FGF23 system].
    Kimura T; Shiizaki K; Kuro-O M
    Clin Calcium; 2016 Jun; 26(6):859-66. PubMed ID: 27230841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. α-Klotho's effects on mineral homeostasis are fibroblast growth factor-23 dependent.
    Erben RG
    Curr Opin Nephrol Hypertens; 2018 Jul; 27(4):229-235. PubMed ID: 29851418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis.
    Mace ML; Olgaard K; Lewin E
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factor 23 and Klotho are present in the growth plate.
    Raimann A; Ertl DA; Helmreich M; Sagmeister S; Egerbacher M; Haeusler G
    Connect Tissue Res; 2013; 54(2):108-17. PubMed ID: 23206185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroblast growth factor 23/klotho axis in chronic kidney disease.
    Nitta K; Nagano N; Tsuchiya K
    Nephron Clin Pract; 2014; 128(1-2):1-10. PubMed ID: 25402964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism.
    Kuro-o M
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):437-41. PubMed ID: 16775459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and localization of fibroblast growth factor (FGF)23 and Klotho in the spleen: its physiological and functional implications.
    Nakashima Y; Mima T; Yashiro M; Sonou T; Ohya M; Masumoto A; Yamanaka S; Koreeda D; Tatsuta K; Hanba Y; Moribata M; Negi S; Shigematsu T
    Growth Factors; 2016 Dec; 34(5-6):196-202. PubMed ID: 28095739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO.
    Xiao L; Naganawa T; Lorenzo J; Carpenter TO; Coffin JD; Hurley MM
    J Biol Chem; 2010 Jan; 285(4):2834-46. PubMed ID: 19933269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential regulation of renal Klotho and FGFR1 in normal and uremic rats.
    Muñoz-Castañeda JR; Herencia C; Pendón-Ruiz de Mier MV; Rodriguez-Ortiz ME; Diaz-Tocados JM; Vergara N; Martínez-Moreno JM; Salmerón MD; Richards WG; Felsenfeld A; Kuro-O M; Almadén Y; Rodríguez M
    FASEB J; 2017 Sep; 31(9):3858-3867. PubMed ID: 28515153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of FGF23 in CKD--with or without Klotho.
    Komaba H; Fukagawa M
    Nat Rev Nephrol; 2012 Jun; 8(8):484-90. PubMed ID: 22714041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast growth factor 23, Klotho, and disordered mineral metabolism in chronic kidney disease: unraveling the intricate tapestry of events and implications for therapy.
    Gutiérrez OM
    J Ren Nutr; 2013 May; 23(3):250-4. PubMed ID: 23611556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.